RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Digitalis Ventures
D

Digitalis Ventures portfolio

Digitalis Ventures has 12 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 12.
Deals, last 12 months: 3.
Rounds led: 2 of 9.
Capital in their rounds: $989.19M.
Latest deal: T-Therapeutics · Nov 5, 2026.
About this page

It is a venture capital firm based in New York, US, founded in 2016. It led 2 of the 9 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Cambridge Innovation Capital, Johnson & Johnson Innovation, Samsara Biocapital and 6 others. By category, its portfolio leans toward Health and bio (11) and Education (2). It has co-invested with Sanofi Ventures, Sofinnova Partners and F-Prime Capital, most often Sanofi Ventures (5 rounds).

About Digitalis Ventures

Firm type: Venture capital.
Headquarters: New York, US.
Founded: 2016.
Stages: Seed, Series A.
Sectors: Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Check size: $100K to $10M.
Leads rounds: Yes.
Portfolio companies: 19.
Exits: 3.
Rounds led: 6.

Funds raised

FundFund #SizeAnnounced
DDigitalis Ventures
NYC
Ifirst fund$100Mvia Shai Goldman's fund list

What Digitalis Ventures invests in

Digitalis Ventures recent investments

How Digitalis Ventures invests

StageDealsCapital in rounds
Series B+ 5 56%$733.19M
Series A 3 33%$250M
Seed 1 11%$6M
YearDealsCapital in rounds
2022 1 11%$100M
2023 1 11%$59M
2024 2 22%$435M
2025 2 22%$106.19M
2026 3 33%$289M

Digitalis Ventures portfolio companies

CompanyRound with Digitalis VenturesTotal raisedLatest raise
TT-Therapeutics
Health and bio
Series B+ · $133M$283MNov 5, 2026
Series B+
MMatchpoint Therapeutics
Health and bio
Series B+ · $150M$250MOct 7, 2026
Series B+
SSparkle
Consumer and social
Seed · $6M · lead$6MSep 9, 2026
Seed
NNapo
Fintech
Series B+ · $15.19M$32.35MFeb 28, 2025
Series B+
AAlpha-9 Oncology
Health and bio
Series B+ · $175M$175MOct 23, 2024
Series B+
CCardurion Pharmaceuticals
Health and bio
Series B+ · $260M$260MJul 16, 2024
Series B+
EEnveda
Health and bio
backer$714MSep 23, 2026
Series B+
RReema
Health and bio
backer$19MDec 2, 2025
Series B+
GGirihlet
Health and bio
backerundisclosed—
BBrella Insurance
Insurance
backerundisclosed—
KKingdom
Health and bio
backer$25MJun 25, 2026
Seed
OOmni Pet
Health and bio
backer$14.6MJul 2, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Digitalis Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 9 rounds on Recent Funding that name Digitalis Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Digitalis Ventures, which is a subset of its real portfolio. API: /api/v1/investors/digitalis-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy